Advocating for Sex & Gender Research: Championing Accountability from Public and Private Enterprises

With an increase in publishing guidelines calling for more sex and gender specific research and better diversity and inclusion in clinical trials, this panel discussion considers how to promote accountability across the public and private sphere. How can we ensure that guidelines are adhered to and what role do public-private sector partnerships play in promoting better research practices? What do recent guidelines published by the FDA advocating for health equity in clinical trials really mean for those innovation in the space? Join this session to unpack these questions and to gain insight into how to ensure your business is successfully considering sex and gender throughout the R&D process.